August 7, 2023
Two subtypes of HPV-associated head and neck cancers predict treatment outcomes
Researchers have divided HPV+ head and neck cancers into two distinct subtypes, which can help determine how well patients will respond to therapy.
August 7, 2023
Researchers have divided HPV+ head and neck cancers into two distinct subtypes, which can help determine how well patients will respond to therapy.
August 7, 2020
Wendell Yarbrough, MD, MMHC, and colleagues will build upon research that demonstrated tumor and blood tests developed at UNC Lineberger could effectively determine if a patient's cancer had recurred.